Labshake search
Citations for R&D Systems :
601 - 650 of 1191 citations for 3 hydroxy 20 oxopregn 5 en 21 yl acetate since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cancer Biology 2022Quote: ... human recombinant epidermal growth factor (20 ng/ml; #236-EG-01M, R&D systems, USA), human recombinant fibroblast growth factor (20 ng/ml ...
-
bioRxiv - Microbiology 2023Quote: ... and LYVE-1 conjugated to A647 (clone 223322 R&D systems, used at 20 μg). A temporary glass window (Merk rectangular coverglass ...
-
bioRxiv - Bioengineering 2024Quote: ... Brain sections were then incubated with goat anti-CD31 (1:20, R&D Systems, AF3628), rat anti-GFAP-Alexa Fluor 488 (1:50 ...
-
bioRxiv - Genomics 2024Quote: ... at a 1:20 dilution and Alexa Fluor 647-conjugated O1 (R&D Systems FAB1327R) at a 1:20 dilution.
-
bioRxiv - Immunology 2023Quote: ... and 20 ng/ml mouse IL-12 (R&D Systems, cat. no. 419-ML-050) depending on the experiment.
-
bioRxiv - Physiology 2023Quote: ... The excitation-contraction uncoupler (blebbistatin, 10 – 20 µM, R&D Systems INC, Minneapolis, MN, USA) (35 ...
-
bioRxiv - Neuroscience 2023Quote: ... and 20 ng ml−1 basic fibroblast growth factor (FGF2; R&D Systems, 233-FB) for 16 d ...
-
bioRxiv - Neuroscience 2024Quote: ... and basic fibroblast growth factor (bFGF, 20 ng ml-1, R&D Systems, 233-FB) until day 24 ...
-
bioRxiv - Bioengineering 2023Quote: ... + 20 ng/ml recombinant mouse macrophage colony-stimulating factor (M-CSF, R&D systems, 416ML010)) for 6-7 days ...
-
bioRxiv - Neuroscience 2023Quote: ... supplemented with 20 ng/mL recombinant human basic FGF (#233-FB, R&D Systems, Germany) and 10 µM Y-27632 (only for the first 24 h after passaging ...
-
bioRxiv - Cell Biology 2023Quote: ... and grown in BrainPhys Neuronal Medium (STEMCELL) containing 20 ng/ml bFGF (R&D Systems), 20 ng/ml EGF (Millipore Sigma) ...
-
bioRxiv - Developmental Biology 2020Quote: ... mouse anti-Nkx2-5 (25 μg/ml, R&D Systems, #259416), rabbit anti-MYL7 (1:1000 ...
-
bioRxiv - Microbiology 2021Quote: ... 5 ng/mL BMP-4 (314-BP-050, R&D Systems), 50 ng/mL VEGF (293-VE-500 ...
-
bioRxiv - Molecular Biology 2022Quote: ... mice were treated with 5 µg RSPO3 (R&D systems #4120RS025CF) in 100 µL PBS 18 ...
-
bioRxiv - Neuroscience 2020Quote: ... SCH 23390 hydrochloride (5 μM; R&D Systems, Minneapolis, MN, USA) was added to the aCSF ...
-
bioRxiv - Immunology 2021Quote: ... and recombinant human IL-1β (5 units/mL; R&D Systems) in the presence or absence of PAD2/PAD4 inhibitor (5 μM YW3-56 ...
-
bioRxiv - Neuroscience 2021Quote: ... 5 ng/mL HB-EGF (R&D Systems, 259-HE-050), 10 ng/mL CNTF (R&D Systems ...
-
bioRxiv - Cancer Biology 2020Quote: ... and 5 ng/ml recombinant human TGF-β (R&D Systems). After 72 h ...
-
bioRxiv - Microbiology 2020Quote: ... supplemented with 5% fetal bovine serum (FBS, R&D SYSTEMS, S11150) and 1% penicillin/streptomycin (P/S ...
-
bioRxiv - Immunology 2020Quote: ... and 5 μg of anti-ACE2 antibody (R&D systems, AF933) or isotope control IgG (R&D systems ...
-
bioRxiv - Neuroscience 2023Quote: ... Membranes were blocked in 5% nonfat skim milk (R&D Systems) for 1 h at room temperature ...
-
bioRxiv - Molecular Biology 2023Quote: ... and growth factors: 5 ng/ml BMP-4 (R&D Systems), 9 ng/ml Activin A (R&D Systems) ...
-
bioRxiv - Immunology 2023Quote: ... supplemented with 5 ng/ml BMP4 (R&D Systems, 314-BP), 50 ng/ml VEGF (R&D Systems ...
-
bioRxiv - Immunology 2023Quote: ... supplemented with 5% fetal bovine serum (R&D systems; cat# S11150), 0.4 μg/ml hydrocortisone (Sigma ...
-
bioRxiv - Cancer Biology 2024Quote: ... and recombinant human IL-7 (5 ng/mL) (R&D Systems).
-
bioRxiv - Biochemistry 2023Quote: ... (v) 5 µg/ml human DC-SIGN-Fc (R&D System), 5 µg/ml human MGL-Fc (R&D System ...
-
bioRxiv - Neuroscience 2023Quote: ... 5 ng/mL HB-EGF (R&D Systems 259-HE-050), and 20 ng/mL FGF-2 (R&D Systems ...
-
bioRxiv - Immunology 2024Quote: ... and 5 µg/ml anti-GM-CSF (MP122E9, R&D Systems) or 1 µg/ml anti-PECAM-1 (MEC13.3 ...
-
bioRxiv - Developmental Biology 2024Quote: ... media was replaced with 5 ng/ml FGF2 (R&D Systems), 15 ng/ml VEGF (Peprotech) ...
-
bioRxiv - Genetics 2024Quote: ... and 5 ng/ml recombinant human IL-15 (R&D Systems). After two days of activation ...
-
bioRxiv - Cell Biology 2024Quote: ... 5 ng/mL HB-EGF (R&D Systems, 259-HE-050), 1X B27 supplement (Gibco ...
-
bioRxiv - Developmental Biology 2024Quote: ... 10 ng/mL GDF-5 (R&D Systems, Minneapolis, MN, USA), and 0.05 mM L-ascorbic acid 2-phosphate ...
-
bioRxiv - Molecular Biology 2021Quote: ... in the presence of IL-3 (1 ng/mL, R&D Systems, Minneapolis, MN, USA) at 37°C and 5% CO2 ...
-
bioRxiv - Microbiology 2020Quote: ... phosphorylated CREB (pCREB) and cleaved caspase-3 were measured using ELISA kits (R&D Systems) according to the manufacturer’s instructions.
-
bioRxiv - Cancer Biology 2022Quote: ... and human FMS like tyrosine kinase 3 ligand (FLT3L, 100 ng/mL, R&D Systems).
-
bioRxiv - Physiology 2020Quote: ... 3-day-old pups were intraperitoneally injected with sterile murine rIGF-1 (R&D systems) or sterile PBS daily at a dose of 200μg/kg until weaning age (21-days-old ...
-
bioRxiv - Microbiology 2023Quote: ... and recombinant mouse IL-3 (10 ng/mL; R&D Systems, Cat. No. 403-ML). Cells were plated at a density of 1 × 106 cells/mL in a T-75 cm2 flask ...
-
bioRxiv - Cell Biology 2023Quote: Primary antibodies used for immunofluorescent staining were: active caspase-3 (Rabbit, R&D Systems, AF835); laminin alpha3 chain (Mouse ...
-
bioRxiv - Cell Biology 2022Quote: ... then plated into T175 flasks with Interleukin-3 (IL3, R&D Systems, 203-IL-050) and macrophage colony-stimulating factor (M-CSF ...
-
bioRxiv - Genomics 2024Quote: ... and 1 ng/mL recombinant human interleukin IL-3 (R&D systems, 203-IL/CF). Phase 2 includes phase 1 media without IL-3 and phase 3 includes phase 1 media without IL-3 and SCF with holo-transferrin increased to 1 mg/mL final concentration ...
-
bioRxiv - Cell Biology 2022Quote: ... These M0 adherent macrophages were activated with 20 ng/ml IFN-gamma (R&D Systems, USA) and 10pg/ ml of LPS (Sigma ...
-
bioRxiv - Bioengineering 2022Quote: ... this medium was further supplemented with 20 ng/mL bFGF (R&D Systems, Minneapolis, MN, USA). On day 6 post induction ...
-
bioRxiv - Molecular Biology 2021Quote: ... epidermal growth factor (EGF, 20 ng/mL, Cat. #236-EG; R&D Systems, Minneapolis, MN, USA), basic fibroblast growth factor (bFGF ...
-
bioRxiv - Molecular Biology 2022Quote: ... M2 macrophages were generated by stimulating Mϕ with 20 ng/ml IL-4 (R&D Systems) and 20 ng/ml IL-13 (R&D system ...
-
bioRxiv - Neuroscience 2023Quote: ... and human fibroblast growth factor 2 (hFGF2) (20 ng/mL, R&D systems 233-FB-025) freshly added into the media ...
-
bioRxiv - Genetics 2023Quote: ... 0.2% PrimocinTM and macrophage colony-stimulating factor (M-CSF) (20 ng/mL; R&D systems; USA) and receptor activator of nuclear factor kappa-B ligand (RANKL ...
-
bioRxiv - Neuroscience 2023Quote: ... media was switched to Basal Neural Maintenance Media with 20 ng/mL FGF (R&D Systems) and fed daily ...
-
bioRxiv - Immunology 2023Quote: ... and stimulated with 0.3 μg/ml HEL plus 20 ng/ml IL-4 (R&D Systems), 0.2 μg/ml CpG (InvivoGen ...
-
bioRxiv - Biochemistry 2023Quote: ... 20 ng/ml recombinant human IL-17A (rhIL-17A, R&D Systems, #7955-IL-025/CF) was used to treat the cells for 10 or 30 minutes ...
-
bioRxiv - Immunology 2022Quote: ... USA) and cultured for 7 days with 20 ng/ml recombinant M-CSF (R&D Systems) to allow them to differentiate to macrophages ...